SNC-LAVALIN ACQUIRES TCPI AND NORTHSTAR IN THE USA
SNC-Lavalin is pleased to announce that it has acquired two companies, The Construction Partnership, Inc. (TCPI) and NorthStar CV, Inc., both based in the State of Pennsylvania, USA. These acquisitions increase SNC-Lavalin’s pharmaceutical and biotechnology team by about 50 people to over 700 employees worldwide.
"This region is one of the key biotechnological and pharmaceutical research and manufacturing areas in the USA," said Daniel Lachapelle, Senior Vice-President and General Manager, SNC-Lavalin Engineering & Technology. "These acquisitions will give us a solid foothold from which to serve our regional and global customers based in the United States."
TCPI has been providing engineering consulting and construction services to the pharmaceutical and life sciences sectors from its offices in Exton and Allentown since 1985. NorthStar CV has been providing compliance, commissioning and validation services to the biotechnology and pharmaceutical industries from its office in Exton since 2003.
"These acquisitions are in line with our strategy to further develop our global biopharmaceutical resources," said Pierre Anctil, Executive Vice-President, SNC-Lavalin Group Inc. "They also allow us to enhance our critical mass of resources in the healthcare/institutional sectors, and to support other SNC-Lavalin divisions worldwide."
SNC-Lavalin (TSX: SNC) is one of the leading groups of engineering and construction companies in the world, a major player in the ownership of infrastructure, and in operations and maintenance services. The SNC-Lavalin companies have offices across Canada and in 30 other countries around the world and are currently working in some 100 countries.
-30-
Media Contact
Gillian MacCormackVice-President, Global Public Relations
SNC-Lavalin Group Inc.
514-393-8000 x7354
gillian.maccormack@snclavalin.com
Investors
Stéphane RoyVice-President, Investor Relations
SNC-Lavalin Group Inc.
514-393-1000 x7559
stephane.roy@snclavalin.com





